Retracted: Clinical Comparative Study of Intravitreal Injection of Triamcinolone Acetonide and Aflibercept in the Treatment of Diabetic Retinopathy Cystoid Macular Edema

Bibliographic Details
Main Author:	Emergency Medicine International
Format:	Article
Language:	English
Published:	Wiley 2024-01-01
Series:	Emergency Medicine International
Online Access:	http://dx.doi.org/10.1155/2024/9787343
Tags:	Add Tag No Tags, Be the first to tag this record!

Clinical Comparative Study of Intravitreal Injection of Triamcinolone Acetonide and Aflibercept in the Treatment of Diabetic Retinopathy Cystoid Macular Edema
by: Yanxia Zhu, et al.
Published: (2022-01-01)

Suprachoroidal Versus Intravitreal Injection of Triamcinolone Acetonide As Primary Treatment For Diabetic Macular Edema
by: Fatima Shafqat Khan, et al.
Published: (2023-12-01)

Adjunct Intravitreous Triamcinolone Acetonide in the Treatment of Diabetic Macular Edema with Anti-VEGF Agents
by: Robert B. Garoon, et al.
Published: (2016-01-01)

Sub-Tenon Injections of Triamcinolone Acetonide Had Limited Effect on Cystoid Macular Edema Secondary to Nanoparticle Albumin-Bound-Paclitaxel (Abraxane)
by: Naoki Matsuoka, et al.
Published: (2015-01-01)

Cystoid Macular Edema in Bietti's Crystalline Retinopathy
by: Ali Osman Saatci, et al.
Published: (2014-01-01)

Choroidal Structural Changes of Posterior Subtenon Triamcinolone Acetonide Injection in Eyes with Refractory Diabetic Macular Edema
by: Bing Liu, et al.
Published: (2022-01-01)

Bilateral Severe Sterile Inflammation with Hypopyon after Simultaneous Intravitreal Triamcinolone Acetonide and Aflibercept Injection in a Patient with Bilateral Marked Rubeosis Associated with Ocular Ischemic Syndrome
by: Ceren Durmaz Engin, et al.
Published: (2017-01-01)

Risk Factors for Refractory Diabetic Macular Oedema after Sub-Tenon’s Capsule Triamcinolone Acetonide Injection
by: Toshiyuki Oshitari, et al.
Published: (2015-01-01)

Comparison of Intravitreal Aflibercept and Ranibizumab following Initial Treatment with Ranibizumab in Persistent Diabetic Macular Edema
by: Ali Demircan, et al.
Published: (2018-01-01)

Intravitreal Aflibercept as a Rescue Therapy for Retinal Neovascularization and Macular Edema due to Eales Disease
by: Ning-Yi Hsia, et al.
Published: (2021-01-01)

Effect of Vitreous Reflux after Intravitreal Aflibercept Injection for Macular Edema with Branch Retinal Vein Occlusion: A Real-World Study
by: Tetsuya Muto, et al.
Published: (2024-01-01)

Evaluation of Functional Outcomes and OCT-Biomarkers after Intravitreal Dexamethasone Implant for Postoperative Cystoid Macular Edema in Vitrectomized Eyes
by: Sigrid Freissinger, et al.
Published: (2020-01-01)

Comparative Outcomes of Standard Perioperative Eye Drops, Intravitreal Triamcinolone Acetonide-Moxifloxacin, and Intracameral Dexamethasone-Moxifloxacin-Ketorolac in Cataract Surgery
by: Robin K. Kuriakose, et al.
Published: (2022-01-01)

Prostaglandin-Induced Cystoid Macular Edema Following Routine Cataract Extraction
by: Negin Agange, et al.
Published: (2010-01-01)

Combination therapy of intravitreal ranibizumab and sub-tenon triamcinolone for treatment of resistant diabetic macular edema: a clinical study in Egypt
by: Hossam Eldin M. A. Khalil, et al.
Published: (2025-01-01)

Intravitreal Therapy for Diabetic Macular Edema: An Update
by: Claudio Furino, et al.
Published: (2021-01-01)

Comparison of one-year real-world outcomes between red (670 nm) subthreshold micropulse laser treatment and intravitreal aflibercept injection for treatment-naïve diabetic macular edema
by: Wataru Kikushima, et al.
Published: (2025-02-01)

Effect and factors associated with reactivation after intravitreal conbercept or aflibercept in retinopathy of prematurity
by: Chunling Huang, et al.
Published: (2025-01-01)

Clinical Observation of Phacoemulsification Combined with Intravitreal Injection of Conbercept in Cataract Patients with Diabetic Macular Edema
by: Jing Wang, et al.
Published: (2021-01-01)

Five-Month Observation of Persistent Diabetic Macular Edema after Intravitreal Injection of Ozurdex Implant
by: Dominik Zalewski, et al.
Published: (2014-01-01)

Dosing intervals in Comparison of one-year real-world outcomes between red (670 nm) subthreshold micropulse laser treatment and intravitreal aflibercept injection for treatment-naïve diabetic macular edema
by: Kai Ching Peter Leung, et al.
Published: (2025-02-01)

Cystoid Macular Edema 18 Years after Anterior Chamber Phakic Intraocular Lens Implantation
by: Elias L. Warrak, et al.
Published: (2022-01-01)

Coats’ Disease-Related Macular Edema Treated with Combined Aflibercept and Laser Photocoagulation
by: Wen-Shi Shieh, et al.
Published: (2017-01-01)

Intravitreal Injections for Macular Edema Secondary to Retinal Vein Occlusion: Long-Term Functional and Anatomic Outcomes
by: Emilia Maggio, et al.
Published: (2020-01-01)

Switch to Aflibercept in Diabetic Macular Edema Patients Unresponsive to Previous Anti-VEGF Therapy
by: Filipe Mira, et al.
Published: (2017-01-01)

Efficacy and Safety of Intravitreal Conbercept, Ranibizumab, and Triamcinolone on 23-Gauge Vitrectomy for Patients with Proliferative Diabetic Retinopathy
by: Jinglin Cui, et al.
Published: (2018-01-01)

Effects of Vitrectomy on Recurrent Macular Edema due to Branch Retinal Vein Occlusion after Intravitreal Injection of Bevacizumab
by: Tatsuya Yunoki, et al.
Published: (2013-01-01)

Intraocular inflammation after intravitreal injection of aflibercept 8 mg for treatment-refractory neovascular age-related macular degeneration: a case report
by: Nozomu Hashiya, et al.
Published: (2025-01-01)

Twelve-Month Outcomes and Optical Coherence Tomography (OCT) Biomarkers After Intravitreal Dexamethasone Implantation in Pseudophakic Eyes with Post-Vitrectomy Cystoid Macular Edema (CME)—Refractory to Medical Therapy
by: Francesco Pignatelli, et al.
Published: (2025-01-01)

Intravitreal Aflibercept Outcomes in Patients with Persistent Macular Exudate Previously Treated with Bevacizumab and/or Ranibizumab for Neovascular Age-Related Macular Degeneration
by: David R. Griffin, et al.
Published: (2014-01-01)

Comparisons of Retinal Nerve Fiber Layer Thickness after Indocyanine Green, Brilliant Blue G, or Triamcinolone Acetonide-Assisted Macular Hole Surgery
by: Yoshiharu Toba, et al.
Published: (2014-01-01)

The Analysis of Correlative Factors of Visual Acuity with Intravitreal Conbercept Injection in Macular Edema Associated with Branch Retinal Vein Occlusion
by: Wenjuan Luo, et al.
Published: (2018-01-01)

Comparison of the Efficacy and Safety of Intravitreal Conbercept with Intravitreal Ranibizumab for Treatment of Diabetic Macular Edema: A Meta-Analysis
by: Xiaolei Sun, et al.
Published: (2020-01-01)

Intravitreal Conbercept Injection with and without Grid Laser Photocoagulation in the Treatment of Diffuse Diabetic Macular Edema in Real-Life Clinical Practice
by: Yule Xu, et al.
Published: (2016-01-01)

Evaluating the Treatment of Diabetic Macular Edema with Aflibercept Based on a Regional Network of Ophthalmologic Care Givers
by: Haidar Khalil, et al.
Published: (2023-01-01)

Manufacture and Characterization of Mucoadhesive Buccal Films Based on Pectin and Gellan Gum Containing Triamcinolone Acetonide
by: Felipe Pereira Fernandes, et al.
Published: (2018-01-01)

The combination of rAAV pseudo-lipid nanoparticle and triamcinolone acetonide enables multi-administration to liver
by: Chunmei Gan, et al.
Published: (2025-03-01)

Evaluation of Changes in Macular Perfusion Detected by Optical Coherence Tomography Angiography following 3 Intravitreal Monthly Bevacizumab Injections for Diabetic Macular Edema in the IMPACT Study
by: Ayman G. Elnahry, et al.
Published: (2020-01-01)

Morphological and Functional Outcomes after Intravitreal Dexamethasone Injection for Macular Edema in Patients with Central Vein Occlusion at 48-Week Follow-Up
by: Cristina Nicula, et al.
Published: (2020-01-01)

The Efficacy and Safety of Dexamethasone Intravitreal Implant for Diabetic Macular Edema and Macular Edema Secondary to Retinal Vein Occlusion: A Meta-Analysis of Randomized Controlled Trials
by: Li Xiaodong, et al.
Published: (2022-01-01)

Retracted: Clinical Comparative Study of Intravitreal Injection of Triamcinolone Acetonide and Aflibercept in the Treatment of Diabetic Retinopathy Cystoid Macular Edema

Similar Items

Similar Items